AC Share Price

AC Share Price

NASDAQ: ACIU | Healthcare
$1.95
-$0.18 (-8.45%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

AC Stock Performance

Open
$2.12
Prev. Close
$2.13
Circuit Range
N/A
Day Range
$1.93 - $2.15
Year Range
$1.93 - $3.90
Volume
13,679
Average Traded
$2.08

AC Share Price Today

As of 21 November 2026, AC Immune SA's share price is $1.95. The stock opened at $2.12, compared to its previous close of $2.13. During today's trading session, AC Immune SA's share price traded between $1.93 and $2.15, with an average price of $2.04. Over the past 52 weeks, the stock has recorded a high of $3.90 and a low of $1.93. In terms of performance, AC Immune SA's share price has declined by 26.55% over the last six months and is down 34.34% on a year-on-year basis.

AC Share Price Chart

Line chart of the AC price trend over the selected period. The price fell overall, ranging from 1.93 to 2.15, ending at 1.95.
$1.93$2.15
L
Show Current Price
H

AC Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$4.50B
Return On Equity (TTM)
N/A
Profit Margin
-1972.67%
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

AC Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$4.26$17.60$30.23$4.50
Net Profit-$76.53-$64.49-$56.37-$88.77
Net Profit Margin-1796.48%-366.42%-186.47%-1972.67%
Income ChangeN/A15.73%12.59%-57.48%

AC Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets72.4965.2368.5657.84
Current Assets121.88190.4148.82128.09
Total Assets194.38255.63217.38185.94
Non Current Liabilities18.4919.7110.225.47
Current Liabilities119.33111.6316.1411.48
Total Liabilities137.82131.3426.3616.95
Shareholders' Equity56.56124.29191.02168.99

AC Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-87.2872.89-71.83-79.57
Investing80.07-116.5678.0625.7
Financing-1.29-1.2451.43-1.46

About AC

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

AC Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.20
$1.93
-13.84%
Oct 2026
$2.65
$2.24
-14.83%
Sep 2026
$2.64
$2.63
-2.23%
Aug 2026
$2.20
$2.69
+22.83%
Jul 2026
$2.31
$2.19
-8.18%
Jun 2026
$2.60
$2.38
-10.17%
May 2026
$3.06
$2.65
-12.66%
Apr 2026
$2.89
$3.04
+10.55%
Mar 2026
$2.83
$2.75
-6.46%
Feb 2026
$3.22
$2.94
-7.40%
Jan 2026
$3.19
$3.17
+1.28%
Dec 2025
$2.95
$3.13
+5.56%

AC Share Price FAQs